Investing Profile

Kazumi Shiosaki

Managing Director at MPM BioImpact

Your Intro Paths to Kazumi Shiosaki

Signal uses Gmail to reveal intro paths. Email content is never read.

Networks Kazumi is a member of

Hotmail Network

5844 CONNECTIONS

University of California, Berkeley Network

759 CONNECTIONS

UC Berkeley Network

50 CONNECTIONS

MPM BioImpact Network

34 CONNECTIONS

Takeda Oncology Network

19 CONNECTIONS

Find Kazumi Shiosaki on

Current Investing Position

MPM BioImpact Managing Director

Investments On Record

Kazumi Shiosaki is on these Sector & Stage Rankings

Kazumi Shiosaki's Investments On Record (2)

Company	StageDateRound Size	Total Raised
Twentyeight-Seven Therapeutics	Series AMay 2019$15M Series ASep 2018$65M Series AApr 2016	$80M
Co-investors: Michal Silverberg (Takeda Ventures, Inc.), Henrijette Richter (Sofinnova Partners)
Epizyme	Series BOct 2009$32M	$45M
Co-investors: David Mott (Mott Family Capital), Beth Seidenberg (Kleiner Perkins), Martin Alexander Gershon (Endeavor Venture Funds)

Kazumi Shiosaki's Experience

CEO Booz Allen and HamltonPresent

CEO HotmailPresent

Managing Director MPM BioImpactPresent

SVP Drug Discovery Millennium Pharmaceuticals (Formerly COR Therapeutics)Present

SVP Drug Discovery Takeda OncologyPresent

Managing Director MPM CapitalPresent

CEO Epizyme2007 - 2010

CEO Primera2004 - 2006

SVP Drug Discovery Millennium Pharmaceuticals1997 - 2001

Kazumi Shiosaki's Education

University of California, Berkeley PhD Synthetic Chemistry

UC Berkeley PhD Synthetic Chemistry

Investors who invest with Kazumi Shiosaki

Scouts & Angels Affiliated With Kazumi Shiosaki